Congratulations to our CEO, President and Founder, Dr. Emil Kakkis, on being honored as BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award recipient for his transformative work in rare diseases. Read more.
February 13,
2020
Ultragenyx Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Update
February 6,
2020
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2019 Financial Results and Corporate Update
January 15,
2020
GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome